News and publishing service
for cannabis related companies

LimeLight of The week is

InMed Pharmaceuticals Inc.

View The Complete Profile

InMed Pharmaceuticals Inc. (NASDAQ: INM) is a global leader in the manufacturing and clinical development of rare cannabinoids. InMed is a clinical stage company developing cannabinoid-based pharmaceutical drug candidates, as well as manufacturing technologies for pharmaceutical-grade rare cannabinoids.

The company is dedicated to delivering new therapeutic alternatives to treat conditions with high unmet medical needs. The company is also developing a proprietary manufacturing technology to produce pharmaceutical-grade rare cannabinoids in the lab and has recently announced an LOI to acquire a leading rare cannabinoid manufacturer.

Investment Considerations

  • InMed has a world class leadership team with a successful track record of drug development and commercialization.
  • The company recently announced closing of a $12 million private placement.
  • InMed has a solid and expanding intellectual property portfolio with multiple patents filed.
  • The company recently signed an LOI to acquire rare cannabinoids manufacturer BayMedica.
  • InMed retains all commercial rights to its IntegraSyn manufacturing system.
  • InMed has filed clinical trial applications in several countries as part of a Phase 2 clinical trial of INM-755 (cannabinol) cream in epidermolysis bullosa.
  • The consumer market for cannabinoid-based pharmaceuticals in the United States is forecast to grow to $25 billion by 2025 and to $50 billion by 2029.
View More

Recent Coverage

InvestorNewsBreaks - InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at Cannabis Investor Conference

September 3, 2021 9:15 AM

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol ("CBN"), will be a featured company in the upcoming Cannabis Industry Virtual Investor Conference, slated for Sept. 8–9, 2021; INM’s presentation is scheduled for Sept. 8 at 1:30 p.m. ET. The two-day conference is an exclusive opportunity for cannabis company leaders to share the vision and mission of their companies and meet with potential investors.The conference is hosted by Virtual Investor Conferences (“VIC”) in partnership with KCSA Strategic Communications. VIC is part of OTC Market Group’s suite of investor relations services and is designed to be an interactive forum for publicly traded companies to meet and present directly with investors. The event replicates the look and feel of onsite investor conferences and combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network. “Our 15th virtual conference with the OTC Markets has generated significant interest from both investors and cannabis companies to where we again have extended the conference to two days,” said KCSA Strategic Communications managing director Phil Carlson in the press release. “We look forward to having some of the prominent global players in the cannabis industry present their story to the investment community.”

To register for the event, visit

To view the full press release, visit


Receive SMS Text Alerts from CannabisNewsWire

Text "Cannabis" to 21000

(US Mobile Phones Only)

Featured Event

NECANN – Growing Local Cannabis Markets
Boston, MA
September 10-12, 2021

Cannabis cultivators, dealers and businesses are invited to attend the NECANN, the largest B2B event on the east coast, being held in Boston on September 10-12, 2021. Operating since 2014, NECANN events are touted as one of the largest cannabis events on the east coast.

The NECANN events attract a huge number of Hemp, MMJ and Cannabis industry professionals in the Northeast to their annual Boston Cannabis Convention. These events are the home base for the New England cannabis industry.

With recreational marijuana legal in Massachusetts, the crowds at the event have grown phenomenally. The event will be attended by industry stalwarts and cannabis leaders who offer their insights on the latest trends, regulations ad growth prospects of the cannabis industry. The New England Cannabis Convention in Boston offers robust networking, communication and business opportunity for cannabis growers, consumers and business cultivators across the region.

For more details about the event, please visit

Conference Highlights

  • The NECANN 2021, the largest, and the longest running B2B event on the east coast is being held in Boston this year
  • Cannabis cultivators, growers, businesses, and enthusiasts are invited to attend the NECANN, on September 10-12, 2021
  • Running in its 7th year, the 2021 New England Cannabis Convention, will be attended by over 300 exhibitors and 10,000 attendees

Upcoming Events

View All Conferences

About CannabisNewsWire (CNW)

CannabisNewsWire (CNW) is a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging a professional team of journalists and writers, CNW introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network of over 5,000 key distribution outlets. Cutting through information overload, CNW's innovative and proprietary systems clearly and succinctly deliver its clients much needed visibility, recognition and brand awareness. CNW is where news, content and information converge.

Stay Informed
We will be posting information about the presenting companies as they take the stage.

See The Latest

Connect With Us
Follow us on social media for the latest news and information from our network of brands and clients.

follow us on twitter  meet on linkedin  like us on facebook


303 S Broadway, Denver, CO 80209 (303) 498-7722

Copyright © 2019. All Rights Reserved.